Edge Wealth Management Has Lowered Chevron (CVX) Holding By $3.93 Million; Regulus Therapeutics Inc. (RGLS) Covered By 3 Bulls

February 15, 2018 - By Marie Mckinney

Edge Wealth Management Llc decreased Chevron Corp (CVX) stake by 61.66% reported in 2017Q3 SEC filing. Edge Wealth Management Llc sold 33,620 shares as Chevron Corp (CVX)’s stock declined 3.45%. The Edge Wealth Management Llc holds 20,905 shares with $2.45M value, down from 54,525 last quarter. Chevron Corp now has $212.14 billion valuation. The stock decreased 0.73% or $0.82 during the last trading session, reaching $111.69. About 1.04M shares traded. Chevron Corporation (NYSE:CVX) has risen 6.68% since February 15, 2017 and is uptrending. It has underperformed by 10.02% the S&P500.

Among 7 analysts covering Regulus Therapeutics (NASDAQ:RGLS), 3 have Buy rating, 0 Sell and 4 Hold. Therefore 43% are positive. Regulus Therapeutics had 28 analyst reports since August 5, 2015 according to SRatingsIntel. BMO Capital Markets initiated the shares of RGLS in report on Tuesday, April 12 with “Outperform” rating. The rating was downgraded by BMO Capital Markets to “Market Perform” on Tuesday, June 28. Chardan Capital Markets maintained the shares of RGLS in report on Tuesday, June 7 with “Buy” rating. Chardan Capital Markets initiated the stock with “Buy” rating in Wednesday, April 13 report. The stock of Regulus Therapeutics Inc. (NASDAQ:RGLS) has “Market Perform” rating given on Monday, January 30 by Wells Fargo. Chardan Capital Markets maintained it with “Buy” rating and $13.50 target in Tuesday, June 28 report. The firm has “Buy” rating by Needham given on Tuesday, June 28. Wedbush maintained Regulus Therapeutics Inc. (NASDAQ:RGLS) on Thursday, February 8 with “Buy” rating. BMO Capital Markets maintained the shares of RGLS in report on Wednesday, November 8 with “Market Perform” rating. On Wednesday, August 2 the stock rating was maintained by BMO Capital Markets with “Market Perform”. See Regulus Therapeutics Inc. (NASDAQ:RGLS) latest ratings:

08/02/2018 Broker: Wedbush Rating: Buy New Target: $4.0 Maintain
05/01/2018 Broker: Leerink Swann Rating: Outperform New Target: $2 Initiates Coverage On
20/12/2017 Broker: Wedbush Rating: Buy New Target: $4.0 Maintain
11/12/2017 Broker: Wedbush Rating: Buy New Target: $4.0 Maintain
08/11/2017 Broker: BMO Capital Markets Rating: Market Perform Old Target: $1.15 New Target: $1 Maintain
03/10/2017 Broker: Needham Rating: Hold Maintain

Among 34 analysts covering Chevron Corporation (NYSE:CVX), 24 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. Chevron Corporation had 114 analyst reports since August 4, 2015 according to SRatingsIntel. As per Wednesday, December 2, the company rating was upgraded by Citigroup. The rating was maintained by Scotia Capital with “Buy” on Thursday, December 21. As per Friday, July 21, the company rating was maintained by Citigroup. Barclays Capital maintained the shares of CVX in report on Monday, October 12 with “Equal-Weight” rating. The firm has “Hold” rating by Societe Generale given on Wednesday, October 18. RBC Capital Markets maintained Chevron Corporation (NYSE:CVX) on Tuesday, September 19 with “Sell” rating. The firm has “Buy” rating given on Tuesday, October 3 by Bank of America. The company was upgraded on Friday, September 11 by JP Morgan. The firm has “Peer Perform” rating given on Tuesday, September 29 by Wolfe Research. The stock of Chevron Corporation (NYSE:CVX) has “Hold” rating given on Tuesday, August 4 by S&P Research.

Since August 16, 2017, it had 0 insider purchases, and 1 sale for $3.06 million activity. On Wednesday, August 16 Deily Linnet F sold $248,274 worth of Chevron Corporation (NYSE:CVX) or 2,312 shares. Pate R. Hewitt also sold $3.06 million worth of Chevron Corporation (NYSE:CVX) shares.

Investors sentiment decreased to 0.95 in Q3 2017. Its down 0.08, from 1.03 in 2017Q2. It turned negative, as 43 investors sold CVX shares while 696 reduced holdings. 121 funds opened positions while 584 raised stakes. 1.18 billion shares or 1.43% more from 1.16 billion shares in 2017Q2 were reported. Ronna Sue Cohen reported 4,752 shares. Foster Dykema Cabot Ma has 2,408 shares. Yhb reported 0.67% of its portfolio in Chevron Corporation (NYSE:CVX). Schmidt P J Invest Mgmt invested in 2% or 56,937 shares. Provise Mngmt Grp Ltd has 0.31% invested in Chevron Corporation (NYSE:CVX). The Massachusetts-based Aureus Asset Management Limited Liability Company has invested 0.1% in Chevron Corporation (NYSE:CVX). Iberiabank Corporation stated it has 0.86% in Chevron Corporation (NYSE:CVX). Checchi Capital Advisers Lc accumulated 0.23% or 19,678 shares. 37,191 were accumulated by Gilman Hill Asset Limited. Brookstone Cap has invested 0.56% in Chevron Corporation (NYSE:CVX). First Commonwealth Pa reported 3,647 shares. Whittier Communication Of Nevada invested in 134,610 shares. Wunderlich Managemnt invested in 12,479 shares. Meiji Yasuda Life Insur has 33,304 shares. Northern Tru accumulated 27.10 million shares.

Edge Wealth Management Llc increased Bp Plc (NYSE:BP) stake by 90,622 shares to 315,151 valued at $12.11 million in 2017Q3. It also upped Nuveen Credit Strat Inc Fd (JQC) stake by 46,066 shares and now owns 168,752 shares. Allergan Plc was raised too.

Investors sentiment increased to 1.35 in Q3 2017. Its up 0.74, from 0.61 in 2017Q2. It is positive, as 9 investors sold Regulus Therapeutics Inc. shares while 11 reduced holdings. 11 funds opened positions while 16 raised stakes. 58.85 million shares or 159.76% more from 22.65 million shares in 2017Q2 were reported. Deutsche Retail Bank Ag holds 515,009 shares or 0% of its portfolio. Eqis Cap Mgmt Incorporated stated it has 24,074 shares or 0% of all its holdings. 397,728 are owned by Millennium Management Ltd Liability Co. Mariner Wealth Advsrs Limited Liability holds 0% in Regulus Therapeutics Inc. (NASDAQ:RGLS) or 37,400 shares. Bnp Paribas Arbitrage holds 4 shares. Retail Bank Of Mellon Corp accumulated 34,189 shares or 0% of the stock. Dowling & Yahnke Ltd Limited Liability Company has invested 0% of its portfolio in Regulus Therapeutics Inc. (NASDAQ:RGLS). Brookstone owns 0% invested in Regulus Therapeutics Inc. (NASDAQ:RGLS) for 13,200 shares. Wells Fargo And Mn owns 492,191 shares. State Street invested in 26,000 shares or 0% of the stock. D E Shaw & invested in 0% or 29,728 shares. Northern Corp, a Illinois-based fund reported 187,492 shares. The Ohio-based Victory has invested 0% in Regulus Therapeutics Inc. (NASDAQ:RGLS). Blackrock Incorporated accumulated 809,320 shares. South Dakota Invest Council invested in 0.05% or 1.82M shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: